| Year |
Citation |
Score |
| 2021 |
Ashok P, Tzanakakis ES. Proteomic Analysis of Exosomes during Cardiogenic Differentiation of Human Pluripotent Stem Cells. Cells. 10. PMID 34685602 DOI: 10.3390/cells10102622 |
0.487 |
|
| 2020 |
Jacobson EF, Chen Z, Stoukides DM, Nair GG, Hebrok M, Tzanakakis ES. Non-xenogeneic Expansion and Definitive Endoderm Differentiation of Human Pluripotent Stem Cells in an Automated Bioreactor. Biotechnology and Bioengineering. PMID 33205831 DOI: 10.1002/bit.27629 |
0.561 |
|
| 2020 |
Ashok P, Parikh A, Du C, Tzanakakis ES. Xenogeneic-Free System for Biomanufacturing of Cardiomyocyte Progeny From Human Pluripotent Stem Cells. Frontiers in Bioengineering and Biotechnology. 8: 571425. PMID 33195131 DOI: 10.3389/fbioe.2020.571425 |
0.599 |
|
| 2020 |
Nair GG, Tzanakakis ES, Hebrok M. Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy. Nature Reviews. Endocrinology. PMID 32587391 DOI: 10.1038/S41574-020-0375-3 |
0.468 |
|
| 2019 |
Chen Z, Downing S, Tzanakakis ES. Four Decades After the Discovery of Regenerating Islet-Derived (Reg) Proteins: Current Understanding and Challenges. Frontiers in Cell and Developmental Biology. 7: 235. PMID 31696115 DOI: 10.3389/Fcell.2019.00235 |
0.33 |
|
| 2019 |
Zhang F, Tzanakakis ES. Amelioration of diabetes in a murine model upon transplantation of pancreatic β-cells with optogenetic control of cyclic AMP. Acs Synthetic Biology. PMID 31518106 DOI: 10.1021/Acssynbio.9B00262 |
0.342 |
|
| 2018 |
Jacobson EF, Tzanakakis ES. Who Will Win: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells for β Cell Replacement and Diabetes Disease Modeling? Current Diabetes Reports. 18: 133. PMID 30343423 DOI: 10.1007/S11892-018-1109-Y |
0.642 |
|
| 2017 |
Zhang F, Tzanakakis ES. Optogenetic regulation of insulin secretion in pancreatic β-cells. Scientific Reports. 7: 9357. PMID 28839233 DOI: 10.1038/S41598-017-09937-0 |
0.316 |
|
| 2017 |
Jacobson EF, Tzanakakis ES. Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions. Journal of Biological Engineering. 11: 21. PMID 28680477 DOI: 10.1186/S13036-017-0066-3 |
0.584 |
|
| 2016 |
Fan Y, Zhang F, Tzanakakis ES. Engineering Xeno-Free Microcarriers with Recombinant Vitronectin, Albumin and UV Irradiation for Human Pluripotent Stem Cell Bioprocessing. Acs Biomaterials Science & Engineering. 3: 1510-1518. PMID 28989958 DOI: 10.1021/Acsbiomaterials.6B00253 |
0.65 |
|
| 2015 |
Ashok P, Fan Y, Rostami MR, Tzanakakis ES. Aggregate and Microcarrier Cultures of Human Pluripotent Stem Cells in Stirred-Suspension Systems. Methods in Molecular Biology (Clifton, N.J.). PMID 26659793 DOI: 10.1007/7651_2015_312 |
0.67 |
|
| 2015 |
Rostami MR, Wu J, Tzanakakis ES. Inverse problem analysis of pluripotent stem cell aggregation dynamics in stirred-suspension cultures. Journal of Biotechnology. 208: 70-9. PMID 26036699 DOI: 10.1016/J.Jbiotec.2015.05.018 |
0.72 |
|
| 2015 |
Terranova C, Narla ST, Lee YW, Bard J, Parikh A, Stachowiak EK, Tzanakakis ES, Buck MJ, Birkaya B, Stachowiak MK. Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1). Plos One. 10: e0123380. PMID 25923916 DOI: 10.1371/Journal.Pone.0123380 |
0.412 |
|
| 2015 |
Parikh A, Wu J, Blanton RM, Tzanakakis ES. Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation. Tissue Engineering. Part B, Reviews. 21: 377-392. PMID 25813860 DOI: 10.1089/Ten.Teb.2014.0662 |
0.67 |
|
| 2015 |
Wu J, Fan Y, Tzanakakis ES. Increased culture density is linked to decelerated proliferation, prolonged G1 phase, and enhanced propensity for differentiation of self-renewing human pluripotent stem cells. Stem Cells and Development. 24: 892-903. PMID 25405279 DOI: 10.1089/Scd.2014.0384 |
0.706 |
|
| 2015 |
Fan Y, Wu J, Ashok P, Hsiung M, Tzanakakis ES. Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges. Stem Cell Reviews. 11: 96-109. PMID 25077810 DOI: 10.1007/S12015-014-9544-X |
0.719 |
|
| 2014 |
Wu J, Rostami MR, Cadavid Olaya DP, Tzanakakis ES. Oxygen transport and stem cell aggregation in stirred-suspension bioreactor cultures. Plos One. 9: e102486. PMID 25032842 DOI: 10.1371/Journal.Pone.0102486 |
0.692 |
|
| 2014 |
Chen CK, Law WC, Aalinkeel R, Yu Y, Nair B, Wu J, Mahajan S, Reynolds JL, Li Y, Lai CK, Tzanakakis ES, Schwartz SA, Prasad PN, Cheng C. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. Nanoscale. 6: 1567-72. PMID 24326457 DOI: 10.1039/C3Nr04804G |
0.557 |
|
| 2014 |
Fan Y, Hsiung M, Cheng C, Tzanakakis ES. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Engineering. Part A. 20: 588-99. PMID 24098972 DOI: 10.1089/Ten.Tea.2013.0219 |
0.616 |
|
| 2014 |
Kaplan AD, Lis A, Cimato TR, Tzanakakis ES, Zhou Q, Morales MJ, Rasmusson RL, Bett GC. Enhanced Differentiation of Stem Cell Derived Cardiac Myocytes by Electronic Expression of IK1 Reveals an Atrial-Specific Kv1.5-Like Current Biophysical Journal. 106: 631a. DOI: 10.1016/J.Bpj.2013.11.3490 |
0.474 |
|
| 2013 |
Tzanakakis ES, Hu WS. Stem cell science has made major strides in the last few years. Introduction. Biotechnology Advances. 31: 993. PMID 24176141 DOI: 10.1016/J.Biotechadv.2013.10.004 |
0.563 |
|
| 2013 |
Bett GC, Kaplan AD, Lis A, Cimato TR, Tzanakakis ES, Zhou Q, Morales MJ, Rasmusson RL. Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 10: 1903-10. PMID 24055949 DOI: 10.1016/j.hrthm.2013.09.061 |
0.451 |
|
| 2013 |
Wu J, Tzanakakis ES. Deconstructing stem cell population heterogeneity: single-cell analysis and modeling approaches. Biotechnology Advances. 31: 1047-62. PMID 24035899 DOI: 10.1016/J.Biotechadv.2013.09.001 |
0.754 |
|
| 2013 |
Wu J, Rostami MR, Tzanakakis ES. Stem cell modeling: From gene networks to cell populations. Current Opinion in Chemical Engineering. 2: 17-25. PMID 23914346 DOI: 10.1016/J.Coche.2013.01.001 |
0.745 |
|
| 2013 |
Wu J, Tzanakakis ES. Distinct allelic patterns of nanog expression impart embryonic stem cell population heterogeneity. Plos Computational Biology. 9: e1003140. PMID 23874182 DOI: 10.1371/Journal.Pcbi.1003140 |
0.728 |
|
| 2012 |
Wu J, Tzanakakis ES. Contribution of stochastic partitioning at human embryonic stem cell division to NANOG heterogeneity. Plos One. 7: e50715. PMID 23226362 DOI: 10.1371/Journal.Pone.0050715 |
0.727 |
|
| 2012 |
Parikh A, Stephan AF, Tzanakakis ES. Regenerating proteins and their expression, regulation and signaling. Biomolecular Concepts. 3: 57-70. PMID 22582090 DOI: 10.1515/Bmc.2011.055 |
0.362 |
|
| 2012 |
Lee YW, Terranova C, Birkaya B, Narla S, Kehoe D, Parikh A, Dong S, Ratzka A, Brinkmann H, Aletta JM, Tzanakakis ES, Stachowiak EK, Claus P, Stachowiak MK. A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. Journal of Cellular Biochemistry. 113: 2920-36. PMID 22539306 DOI: 10.1002/Jcb.24170 |
0.381 |
|
| 2012 |
Patil SA, Chandrasekaran EV, Matta KL, Parikh A, Tzanakakis ES, Neelamegham S. Scaling down the size and increasing the throughput of glycosyltransferase assays: activity changes on stem cell differentiation. Analytical Biochemistry. 425: 135-44. PMID 22449497 DOI: 10.1016/J.Ab.2012.03.009 |
0.458 |
|
| 2011 |
Lock LT, Laychock SG, Tzanakakis ES. Pseudoislets in stirred-suspension culture exhibit enhanced cell survival, propagation and insulin secretion. Journal of Biotechnology. 151: 278-86. PMID 21185337 DOI: 10.1016/J.Jbiotec.2010.12.015 |
0.435 |
|
| 2011 |
Jing D, Parikh A, Tzanakakis ES. Stem cell bioprocessing for regenerative medicine Stem Cells: From Mechanisms to Technologies. 197-229. DOI: 10.1142/9789814317931_0007 |
0.702 |
|
| 2011 |
Stachowiak MK, Stachowiak EK, Aletta JM, Tzanakakis ES. A common integrative nuclear signaling module for stem cell development Stem Cells: From Mechanisms to Technologies. 87-132. DOI: 10.1142/9789814317931_0004 |
0.543 |
|
| 2011 |
Stachowiak MK, Tzanakakis ES. Stem cells: From mechanisms to technologies Stem Cells: From Mechanisms to Technologies. 1-377. DOI: 10.1142/7849 |
0.574 |
|
| 2010 |
Jing D, Parikh A, Tzanakakis ES. Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplantation. 19: 1397-412. PMID 20587137 DOI: 10.3727/096368910X513955 |
0.715 |
|
| 2010 |
Jing D, Kehoe DE, Tzanakakis ES. Expression of Reg family proteins in embryonic stem cells and its modulation by Wnt/beta-catenin signaling. Stem Cells and Development. 19: 1307-19. PMID 20050810 DOI: 10.1089/Scd.2009.0398 |
0.669 |
|
| 2010 |
Kehoe DE, Jing D, Lock LT, Tzanakakis ES. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Engineering. Part A. 16: 405-21. PMID 19739936 DOI: 10.1089/Ten.Tea.2009.0454 |
0.748 |
|
| 2009 |
Lock LT, Tzanakakis ES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Engineering. Part A. 15: 2051-63. PMID 19196140 DOI: 10.1089/Ten.Tea.2008.0455 |
0.571 |
|
| 2008 |
Kehoe DE, Lock LT, Parikh A, Tzanakakis ES. Propagation of embryonic stem cells in stirred suspension without serum. Biotechnology Progress. 24: 1342-52. PMID 19194949 DOI: 10.1002/Btpr.57 |
0.619 |
|
| 2008 |
Jing D, Parikh A, Canty JM, Tzanakakis ES. Stem cells for heart cell therapies. Tissue Engineering. Part B, Reviews. 14: 393-406. PMID 18821841 DOI: 10.1089/Ten.Teb.2008.0262 |
0.674 |
|
| 2007 |
Chemler JA, Lock LT, Koffas MA, Tzanakakis ES. Standardized biosynthesis of flavan-3-ols with effects on pancreatic beta-cell insulin secretion. Applied Microbiology and Biotechnology. 77: 797-807. PMID 17938905 DOI: 10.1007/S00253-007-1227-Y |
0.34 |
|
| 2007 |
Lock LT, Tzanakakis ES. Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Engineering. 13: 1399-412. PMID 17550339 DOI: 10.1089/Ten.2007.0047 |
0.572 |
|
| Show low-probability matches. |